Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The Natural Antimicrobial Carvacrol Inhibits Campylobacter jejuni Motility and Infection of Epithelial Cells

  • Lieke B. van Alphen,

    Current address: Statens Serum Institute, Copenhagen, Denmark

    Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands

  • Sara A. Burt,

    Affiliation Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands

  • Andreas K. J. Veenendaal,

    Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands

  • Nancy M. C. Bleumink-Pluym,

    Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands

  • Jos P. M. van Putten

    Affiliation Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands



Natural compounds with anti-microbial properties are attractive reagents to reduce the use of conventional antibiotics. Carvacrol, the main constituent of oregano oil, inhibits the growth of a variety of bacterial foodborne pathogens. As concentrations of carvacrol may vary in vivo or when used in animal feed, we here investigated the effect of subinhibitory concentrations of the compound on major virulence traits of the principal bacterial foodborne pathogen Campylobacter jejuni.

Methods/Principal Findings

Motility assays revealed that subinhibitory concentrations of carvacrol inhibited the motility of C. jejuni without affecting bacterial growth. Immunoblotting and electron microscopy showed that carvacrol-treated C. jejuni still expressed flagella. The loss of motility was not caused by reduced intracellular ATP levels. In vitro infection assays demonstrated that subinhibitory concentrations of carvacrol also abolished C. jejuni invasion of human epithelial cells. Bacterial uptake of invasive Escherichia coli was not blocked by carvacrol. Exposure of C. jejuni to carvacrol prior to infection also inhibited cellular infection, indicating that the inhibition of invasion was likely caused by an effect on the bacteria rather than inhibition of epithelial cell function.


Bacterial motility and invasion of eukaryotic cells are considered key steps in C. jejuni infection. Our results indicate that subinhibitory concentrations of carvacrol effectively block these virulence traits by interfering with flagella function without disturbing intracellular ATP levels. These results broaden the spectrum of anti-microbial activity of carvacrol and support the potential of the compound for use in novel infection prevention strategies.


Campylobacter jejuni is the leading cause of bacterial foodborne disease and a major causative agent of traveler's diarrhea worldwide [1][3]. Symptoms of campylobacteriosis include diarrhea, fever, abdominal cramps and nausea. In a small group of patients serious sequela such as Guillain-Barré syndrome, an acute demyelinating disease of the peripheral nervous system [4], and reactive arthritis [5] contribute to the disease burden. Prolonged or severe Campylobacter infections and infected immunocompromised hosts need antibiotic therapy. However, increasing resistance to various antibiotics and concern for public health [6][8] strengthen the need for novel methods to reduce Campylobacter infections.

Main routes of acquiring C. jejuni infection are the consumption of contaminated meat, in particular poultry [9], and the ingestion of contaminated water [10]. Despite many advances in understanding C. jejuni infection, the exact mechanisms underlying intestinal colonization and disease are still poorly understood. At a cellular level, it is known that C. jejuni requires motility, mediated by its two polar flagella, for colonization and full virulence [11], [12]. Bacteria lacking flagella or expressing a non-motile flagellum show reduced colonization of epithelial cells in vitro [13], [14] and of the chicken intestinal tract in vivo [15]. Other factors implicated in virulence include several outer membrane proteins (including PEB1, JlpA, MOMP and CadF) [16][19], the phase variable capsule [20], [21], protein glycosylation [22] and lipooligosaccharide (LOS) [23][25] (for review: see [26]).

Novel strategies of fighting bacterial infections include the use of essential oil components with antibacterial activity. Carvacrol, a major constituent of oregano oil, is such a substance. It is an approved food flavor both in the US and in Europe and is currently also used as antibacterial feed additive and food preservative [27]. The bacterial target of carvacrol remains to be established. However, when added in bactericidal or growth-inhibitory concentrations, it can induce changes in the fatty acid composition [28], [29] and permeabilize the outer membrane of several Gram-negative species, resulting in leakage of ions and outer membrane-associated material to the medium [30]. Furthermore, in some species carvacrol possesses ATPase-inhibiting activity [31], [32] and has been proposed to act as a proton exchanger that reduces the pH gradient across the cytoplasmic membrane causing a collapse of the proton motive force and depletion of the ATP pool leading to cell death [33]. In Bacillus cereus, addition of carvacrol below the minimum inhibitory concentration (MIC) sharply reduces toxin production, suggesting that lower concentrations of carvacrol may contribute to food safety as well [34].

Most studies on the effects of carvacrol on bacteria have focused on determining the MIC at which growth arrest of the bacterial culture occurs, or on the minimum bactericidal concentration (MBC) i.e. the concentration at which >99.9% of the bacterial population is killed. In the present study, we investigated the potential effects of sub-inhibitory concentrations (subMIC) of carvacrol on the virulence potential of C. jejuni. Exposure of pathogens to subinhibitory concentrations of the compound are likely to occur when added to animal feed or when used during decontamination e.g. during slaughter. Our results indicate that at concentrations that do not affect bacterial growth carvacrol inhibits bacterial motility and invasion of eukaryotic cells which may limit bacterial spread and infection.

Materials and Methods

Bacteria and cell culture

C. jejuni strains 108 (129108, 108WT) [35] and 81116 [36] were routinely grown on saponin agar plates with 6% lysed horse blood (Biotrading) or in 5 ml of Heart Infusion (HI) broth (Biotrading) under microaerophilic conditions at 37°C. E. coli inv, expressing the invasin of Y. pseudotuberculosis [37], was routinely grown on LB agar plates at 37°C. INT-407 (CCL-6, ATCC) intestinal epithelial cells were routinely maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS) in a humidified 37oC atmosphere of 10% CO2.

Growth curves

Carvacrol (Sigma) was dissolved in 96% ethanol to a final concentration of 0.1 M prior to use. The subMIC for C. jejuni (highest concentration of carvacrol that does not inhibit bacterial growth) was determined by measuring the optical density (550 nm) of cultures (final start OD550: 0.05) after incubation under microaerophilic conditions (16 h, 160 rpm, 37°C). To quantify the number of bacteria, serial dilutions were plated, incubated (24 h), and colonies enumerated. Growth kinetics of C. jejuni were determined in HI broth in the absence and presence of 0.2 mM carvacrol by measuring OD550 of the culture at indicated intervals.

Construction of motility deficient mutants

The C. jejuni motAB mutant was constructed as described [38]. PCR was used to amplify the motAB genes and their flanking regions using primers 335fw (5′-TATGATGAGTTTTATGGGCGAGAG-3′) and 338rev (5′-TTGATACCGAAACCACAGGACTTG-3′). This PCR fragment was cloned into the pGEM-Teasy vector in E. coli DH5α. Reverse PCR on the pGEMmotAB, using outward oriented primers motB-Bgl-out (5′-CCCAGATCTTAGGAACTAAAGCACCTTAAAAG-3′) and motA-Bgl-out (5′-CCCAGATCTGTTGAAAGATCCATTAATTATCTCC-3′) was used to delete 1489 bp from motAB and to introduce a unique BglII restriction site that served to insert the Kmr cassette from pMW2, yielding pGEMmotAB:km. This knockout construct was transformed into C. jejuni 81116 and C. jejuni 108 to generate ΔmotAB. Double cross-over recombination events were confirmed by PCR.

Electron microscopy

A drop of bacteria (strain 108) grown in HI broth (16 h) in the presence or absence of 0.2 mM of carvacrol was added onto a 100-mesh grid, coated with 0.7% FormVar (Agar Scientific, Essex, UK). After 10 min, the grids were stained with 2% tungstophosphoric acid for 1 s and allowed to dry. The grid was viewed in a Philips CM10 electron microscope.


To assess protein profiles and flagellin expression, C. jejuni strain 108 was grown overnight in HI broth and then diluted to an optical density at 550 nm of 0.10 into 5 ml of HI broth containing either solvent (ethanol) or various concentrations of carvacrol. After 2 h of incubation (37°C, microarobic conditions, 160 rpm), equal amounts of bacteria were collected (2,000×g, 5 min), mixed with Laemmli buffer, and heated (95°C, 10 min). Aliquots were separated by SDS-PAGE and either stained with Coomassie Brilliant Blue or immunoblotted onto PVDF membranes. Blots were incubated with C. jejuni flagellin rabbit antiserum 313 and, subsequently, with goat-anti rabbit IgG-peroxidase. Blots were developed with Supersignal West Pico chemiluminescent substrate (Pierce Biotechnology).

Motility assays and time-lapse microscopy

To assess bacterial motility in the presence or absence of sub-inhibitory concentrations of carvacrol the well-established soft-agar method was used [39]. In brief, equal numbers of bacteria of C. jejuni strains 108, 81116, 108ΔmotAB or 81116 ΔmotAB grown in HI broth were pipetted into semi-solid medium (thioglycollate medium with 0.4% agar) containing up to 0.1 up to 0.4 mM of carvacrol or an equivalent amount of solvent (ethanol). Bacterial migration through the semi-solid agar was assessed after incubation (24 h) under microaerophilic conditions at 37°C, as described [39].

For dark-field and time-lapse microscopy, C. jejuni strain 108 grown in HI broth in the absence or presence of various concentrations of carvacrol was observed at 1000x magnification under a phase contrast microscope for 1 min and classified by a method established by Gill and Holley [40]. Suspensions which were actively moving and tumbling were classed as motile; suspensions in which a minority of cells of cells were either moving or tumbling were classed as having reduced motility; and suspensions showing only stationary vibrational movement were classed as non motile. In addition, the presence of the coccoid form was noted. Motility was recorded using an Olympus DP25 camera.

ATP measurements

To determine intracellular ATP levels, HI grown (16 h) C. jejuni strain 108 was collected by centrifugation (3,000×g, 10 min, 20°C) and resuspended in HEPES buffered saline (10 mM HEPES, 5.4 mM KCl, 145 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, pH 7.4) to OD550 of 0.05. When appropriate, 20 mM of L-serine, 0.2 mM of carvacrol (or the equivalent amount of solvent ethanol) or 5 μM of carbonyl cyanide-m-chlorophenylhydra­zone (CCCP) were added as supplements. After 2 h of incubation at 37°C under microaerophilic conditions, 1 ml of suspension was centrifuged (3,000×g, 5 min, 20°C) and the cell pellet resuspended in 100 μl of lysis buffer (100 mM Tris, 4 mM EDTA, pH 7.75). Subsequently, 900 μl of boiling lysis buffer was added. Samples incubated for 2 min at 100°C, placed on ice, and centrifuged (1,000×g, 1 min, 4°C). One-hundred microliters of supernatant was mixed with an equal amount of luciferase reagent from the ATP Bioluminescence Assay CLS II kit (Roche) and luciferase activity was measured using a luminometer (TD-20/20, Turner Designs). The ATP concentration was calculated from an ATP standard curve.

Infection and gentamicin protection assay

Infection experiments were carried out as described [41] with some modifications. Briefly, epithelial cells (75–80% confluence) were rinsed twice with serum-free medium and placed in 1 ml of this medium in a microaerobic incubator at 30 min prior to infection. Bacteria, grown in HI broth for 16 h (OD550: 1.2) in the presence or absence of 0.2 mM of carvacrol, were collected by centrifugation (6,000×g, 5 min, 20°C), resuspended in Dulbecco's phosphate buffered saline (DPBS), and added to the cells at an m.o.i. of 200. Where indicated, the plates were centrifuged (600×g, 10 min, 20°C). Bacterial invasion was assessed after 2 h of infection using the gentamicin protection assay. Cells were first rinsed three times with 1 ml of DPBS, then incubated (3 h, 37°C) in 0.5 ml of medium containing 250 μg/ml of gentamicin, rinsed three times with 1 ml of DPBS, lysed with 250 μl of 0.1% Triton X-100 in DPBS (15 min, 20°C), and plated at various dilutions to quantify the number of viable bacteria. Triton X-100 did not influence C. jejuni recovery irrespective of carvacrol treatment. No viable bacteria were recovered from the culture supernatant after gentamicin treatment, indicating that the treatment was effective. Experiments were performed in duplicate and the averages (mean ± SEM) of three separate experiments are presented.

Statistical analysis

Results were analyzed for statistical differences by Student's unpaired t-test, one-way or two-way ANOVA where appropriate. Statistical significance was accepted at p<0.05.


Effect of carvacrol on C. jejuni growth

Most studies on the effects of carvacrol on C. jejuni have focused on the concentrations necessary to partially (MIC) [42] or totally (MBC) [43] inhibit bacterial growth. To investigate whether sub-inhibitory concentrations (subMIC) of carvacrol influence virulence traits of C. jejuni, we first determined the highest concentration of carvacrol that did not inhibit growth of C. jejuni strains 108 and 81116. Bacterial growth was determined after 16 h of incubation under microaerobic conditions in the presence of various concentrations of carvacrol. The highest sub-inhibitory concentration of carvacrol for strains 108 and 81116 was 0.2 mM and 0.25 mM respectively, both when bacteria were grown in HI broth (Fig. 1A) and in tissue culture medium consisting of DMEM enriched with 5% FCS (data not shown). At higher concentrations (≥0.4 mM), bacterial growth was inhibited as judged from the reduced OD550 levels reached after 16 h of incubation (Fig. 1A). Time course experiments performed with strain 108 showed similar growth kinetics in the absence and presence of 0.2 mM of carvacrol during the entire period of incubation (Fig. 1B). Enumeration of colony forming units confirmed the presence of equal numbers of bacteria for both cultures (data not shown).

Figure 1. Effect of carvacrol on C. jejuni growth.

(A) Growth of C. jejuni strains 108 and 81116 in HI supplemented with increasing concentrations of carvacrol as determined after 16 h of incubation. The maximum sub-inhibitory concentration (SIC) is indicated by an arrow. (B) Growth kinetics of C. jejuni strain 108 with or without carvacrol at SIC monitored during a 24 h-period. Results are mean values ± standard error of three independent experiments.

Effect of carvacrol on flagella formation and motility

Flagella-driven bacterial motility is an important virulence trait of C. jejuni. The effect of sub-inhibitory concentration of carvacrol on C. jejuni motility was first assessed for different concentrations of carvacrol. C. jejuni using dark-field microscopy (Table 1). Time-lapse microscopy confirmed that C. jejuni strain 108 became non-motile when grown in HI broth in the presence of 0.2 mM of carvacrol (see Supporting Information, Movie S1 and S2). Strain 81116 became non-motile at 0.25 mM of carvacrol. At concentrations >0.4 mM of carvacrol, both strains gained a coccoid appearance (Table 1). Similar observations were made for bacteria kept in DMEM with carvacrol. The lack of motility was verified in a motility assay in 0.4% thioglycollate soft-agar plates containing increasing concentrations of carvacrol. Again, carvacrol inhibited bacterial migration, while strong migration of the strains was observed in the absence of carvacrol (Fig. 2A and B). The inhibition of the movement in the semi-solid medium required slightly higher concentrations of carvacrol than in HI broth most likely due to the limited diffusion of the compound in the soft-agar. Electron microscopy on C. jejuni grown in HI broth in the absence or presence of 0.2 mM of carvacrol showed that the bacteria carried polar flagella that appeared morphologically similar irrespective the presence of carvacrol (Fig. 3A). Thus, carvacrol seemed to inhibit flagella function rather than flagella biosynthesis. Immunoblotting confirmed the presence of similar amounts of bacterial flagellin in the absence and presence of 0.2 mM of carvacrol (Fig. 3B).

Figure 2. Inhibition of C. jejuni motility by carvacrol.

Swarming of C. jejuni strain 108 (A) and 81116 (B) and the non-motile mutants 108ΔmotAB (C) and in 81116ΔmotAB (D) in thioglycollate agar in the absence and presence of the indicated concentrations of carvacrol after 24 h of growth. The carvacrol solvent ethanol (EtOH) served as negative control.

Figure 3. Effect of carvacrol on flagella formation.

(A) Representative electronmicrographs of flagella-expression by C. jejuni strain 108 (arrows) grown in the absence (left panel) and presence (right panel) of 0.2 mM of carvacrol. Bar represents 1 µm. (B) Western blot of whole cell lysates of C. jejuni strain 108 grown at the indicated concentrations of carvacrol. The blot was probed with rabbit anti-flagella antiserum 313 and subsequently with goat-and-rabbit IgG-peroxidase and substrate. Molecular mass markers are indicated in kilodaltons (kDa).

Table 1. Effect of carvacrol on the motility and physiology of C. jejuni strains 108 and 81116 cultured (16 h) in HI broth with shaking in the absence or presence of the indicated concentrations of carvacrol.

Effect of carvacrol on C. jejuni ATP levels

Previously, high concentrations of carvacrol have been shown to deplete intracellular ATP levels in B. cereus, resulting in cell death [44]. To determine whether the impaired C. jejuni motility was caused by depletion of ATP, bacterial ATP levels were measured using a luciferase assay. This assay demonstrated profoundly reduced ATP levels for C. jejuni strain 108 kept in Hepes buffer compared to Hepes buffer with L-serine as a carbon source (Fig. 4). In the presence of L-serine and carvacrol (0.2 mM), similar ATP levels were detected as with L-serine alone, indicating that carvacrol does not reduce ATP levels in C. jejuni (Fig. 4). Even at growth-inhibitory concentrations of carvacrol (0.4 mM), no reduction of C. jejuni ATP levels was observed (data not shown). A reduction in ATP levels was detected after addition of carbonyl cyanide-m-chlorophenylhydrazone (CCCP), a disruptor of the proton motive force (Fig. 4). This effect was already observed at a concentration (5 μM) that did not inhibit C. jejuni growth. Thus, carvacrol inhibits C. jejuni motility independent of bacterial ATP levels.

Figure 4. Effect of carvacrol on C. jejuni ATP levels.

C. jejuni strain 108 grown in HI broth (16 h) was resuspended in HEPES buffer with or without the indicated supplements. After 2 h incubation at 37°C under microaerophilic conditions, bacterial ATP levels were determined. Results are expressed as the ATP concentration per bacterium and are mean values ± standard error from three independent experiments. ** p≤0.005; *** p≤0.001; n.s. not statistically significant.

Effect of carvacrol on invasion of INT-407 cells by C. jejuni

As flagella are important for C. jejuni invasion of eukaryotic cells and intestinal colonization [12], we next investigated the effect of carvacrol on the invasion properties of C. jejuni. Bacterial entry into cultured epithelial INT-407 cells was measured using a standard gentamicin protection assay [41]. Addition of carvacrol (0.2 mM) during infection (i.e. not during the C. jejuni preculture) reduced C. jejuni invasion levels to as low as 5.6%±1.9% of the invasion observed in the absence of the compound (Fig. 5). When carvacrol was added both during C. jejuni growth and subsequent infection of INT-407 cells, invasion levels further reduced to approximately 0.38%±0.09% (Fig. 5).To determine whether the presence of carvacrol during bacterial growth only was already sufficient to induce a C. jejuni invasion-deficient phenotype, bacteria were grown (16 h) with 0.2 mM of carvacrol, washed, and incubated with INT-407 cells in the absence of carvacrol. This procedure caused a 45.6%±10.8% reduction of bacterial invasion compared to C. jejuni grown in the absence of carvacrol (Fig. 5).

Figure 5. Effect of carvacrol on bacterial invasion of INT-407 cells.

Invasion of INT-407 cells by C. jejuni (strain 108) and E. coli inv in the absence (filled bars) and presence (open bars) of 0.2 mM of carvacrol. Bacteria used for inoculation were grown in HI broth without (−) or with (+) carvacrol. Invasion was determined using the gentamicin protection assay. Note that the reduction in invasion was specific for C. jejuni and most effective when carvacrol was present before and during the infection assay. Results are expressed as percentage of invasion in the absence of carvacrol and are mean values ± standard error from at least three independent experiments. *** p≤0.001; n.s. not statistically significant.

To further establish that carvacrol acted on the pathogen rather than on the uptake capacity of the INT-407 cells, we determined the effect of carvacrol on the invasion of recombinant E. coli expressing the invasin of Yersina pseudotuberculosis [37]. This strain efficiently enters epithelial cells via β1-integrin receptors [45]. Carvacrol caused a minimal decrease in invasion of E. coli inv compared to the drastic reduction of C. jejuni invasion (Fig. 5). This result indicates that carvacrol does not cause a general defect in bacterial uptake in the eukaryotic cells, but specifically inhibits C. jejuni infection.

Partial restoration of invasion in carvacrol-treated C. jejuni

To substantiate the lack of bacterial motility as the cause of the inhibition of bacterial invasion, we performed infection assays in which the bacteria were centrifuged onto the cells, which reduced the requirement for motility to reach the cell surface. Centrifugation of the bacteria onto the cells restored the C. jejuni invasion in the presence of carvacrol from 5.6% (±1.9%) to 25.5% (±3.5%) of the invasion levels observed without carvacrol (Fig. 6). This finding indicates that the inhibition of C. jejuni invasion by carvacrol is at least partially caused by the reduction in bacterial motility.

Figure 6. Partial restoration of invasion in carvacrol-treated C. jejuni.

Invasion of C. jejuni (strain 108) into INT-407 cells was determined in the absence (filled bars) and presence (open bars) of 0.2 mM of carvacrol, without (−) and with (+) centrifugation of the bacteria onto the cells at the start of the infection. Note the five-fold increase in invasion by C. jejuni grown with carvacrol after centrifugation. Results are expressed as percentage of invasion in the absence of carvacrol and are mean values ± standard error of at least three independent experiments. *** p≤0.001.


Natural compounds that limit the spread and virulence of bacterial foodborne pathogens may be attractive alternatives for conventional antimicrobials. For their application as disinfectants and in therapy, it is important to establish the concentration range and mechanism of the anti-microbial activity. Carvacrol is a major component of oregano oil that inhibits the growth of many food-borne pathogens including emerging antibiotic-resistant C. jejuni [42], [43]. Carvacrol has been approved as food flavor in both the USA and Europe, is used as antibacterial feed additive and food preservative [27], and may be used as decontaminant e.g. during slaughter. During these applications local drug concentrations may show large variations which may influence the efficacy of the treatment.

Here we investigated the effect of sublethal and sub-inhibitory concentrations of carvacrol on bacterial behavior to assess its spectrum of biological activities. Our results indicate that even at concentrations that do not impair bacterial growth, carvacrol attenuates C. jejuni virulence and protects against cellular infection. Titration of the effect of carvacrol on bacterial growth revealed that a concentration of ≥0.4 mM was sufficient for complete growth inhibition of C. jejuni strains 108 and 81116. Sub-inhibitory concentrations (here defined as the highest concentration that did not reduce bacterial growth) were determined at 0.2 mM of carvacrol for C. jejuni 108 and 0.25 mM for C. jejuni 81116 (Fig. 1A). At these concentrations, no difference in growth kinetics could be observed between cultures with or without carvacrol (Fig. 1B), but bacterial motility and bacterial invasion of eukaryotic cells were virtually abolished.

Electron microscopy showed C. jejuni with flagella after carvacrol treatment. These results in combination with the measured unaltered flagellin expression as determined by immunoblotting (Fig. 3B) indicate defective flagella function rather than a lack of filament assembly as the most likely molecular basis of the motility defect. This result was unexpected as for E. coli O157:H5 sublethal concentrations of carvacrol have been reported to reduce flagellar synthesis [46]. Due to its hydrophobic properties, carvacrol is predicted to influence the function of biological membranes. It is generally assumed that carvacrol can enter into the cytoplasm of bacterial cells and, at higher concentrations, affects the membrane integrity of E. coli and Listeria monocytogenes [47]. For Bacillus cereus, the bactericidal effect of carvacrol has been attributed to a depletion of intracellular ATP and a dissipation of ion gradients due to increased permeability of the cytoplasmic membrane [33], [44]. In our hands, carvacrol (0.2–0.4 M) did not reduce internal ATP levels of C. jejuni, although such an effect was measured after treatment with a sub-inhibitory concentration of the proton motive force disrupting compound carbonyl cyanide m-chlorophenylhydrazone (CCCP) (Fig. 4). These results indicate that carvacrol inhibits flagellar motility of C. jejuni without depleting bacterial ATP levels.

Gentamicin-protection assays revealed that 0.2 mM of carvacrol was sufficient to inhibit invasion of INT-407 cells by C. jejuni strain 108. The effect of carvacrol was most effective when the compound was present during the infection assay. Carvacrol is known to activate the Ca2+-permeable cation channel TRPV3 that acts as a receptor in oral and nasal epithelium [48]. The reduction in C. jejuni invasion may thus have been caused by an effect on epithelial cell behavior. However, we consider an effect of carvacrol on these eukaryotic uptake pathway(s) unlikely as (partial) inhibition of invasion was also observed when C. jejuni was pre-treated with carvacrol. Additionally, the non-motile but highly invasive E. coli inv [39] was still taken up efficiently by the cells in the presence of carvacrol, suggesting that at least the uptake pathway used by this bacterium is intact in the presence of carvacrol. This scenario is in line with studies that report the bactericidal activity of carvacrol to occur at far lower concentrations than cytotoxic effects on mammalian cells [49]. During the time span of the infection assay, we observed no effects of carvacrol on cellular apoptosis and proliferation. Furthermore, the concentrations of carvacrol used in this study approximate the lowest concentration used in some animal feed studies [50], although 10- to 50-fold higher concentrations are used more commonly [51]. The absence of apparent cytotoxicity and the observed partial restoration of C. jejuni invasion in the presence of carvacrol when the bacteria were centrifuged onto the cells further suggest that the lack of bacterial motility largely accounts for the reduction in invasion. Functional flagella are well known to be required for efficient entry of C. jejuni into eukaryotic cells [13][15], [39].

In conclusion, the present results show for the first time that sub-inhibitory concentrations of carvacrol inhibit C. jejuni motility and invasion into eukaryotic cells. As flagella-mediated motility is required for C. jejuni virulence and the colonization of poultry, our results support and may widen the window for the use of carvacrol as an antibacterial additive or as supplement in animal feed.

Supporting Information

Movie S1.

Time-lapse microscopy showing the movement of C. jejuni strain 108 in the absence of 0.2 mM of carvacrol.


Movie S2.

Time-lapse microscopy showing the movement of C. jejuni strain 108 in the presence of 0.2 mM of carvacrol.



We thank A. Ultee for assistance with electron microscopy.

Author Contributions

Conceived and designed the experiments: LVA SB JVP. Performed the experiments: LVA SB AV NBP. Analyzed the data: LVA SB AV NBP JVP. Wrote the paper: LVA SB JVP.


  1. 1. Allos BM (2001) Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 32: 1201–1206.
  2. 2. Gascon J (2006) Epidemiology, etiology and pathophysiology of traveler's diarrhea. Digestion 73 Suppl 1102–108.
  3. 3. Havelaar AH, van Pelt W, Ang CW, Wagenaar JA, van Putten JP, et al. (2009) Immunity to Campylobacter: its role in risk assessment and epidemiology. Crit Rev Microbiol. 35: 1–22.
  4. 4. Hughes RA, Cornblath DR (2005) Guillain-Barré syndrome. Lancet 366: 1653–1666.
  5. 5. Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, et al. (2002) Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology 41: 312–318.
  6. 6. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL (2002) Human campylobacteriosis in developing countries. Emerg Infect Dis 8: 237–244.
  7. 7. DuPont HL (2007) The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis 45: 1353–1361.
  8. 8. Griggs DJ, Peake L, Johnson MM, Ghori S, Mott A, et al. (2009) Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother 53: 3357–3364.
  9. 9. Butzler JP, Oosterom J (1991) Campylobacter: pathogenicity and significance in foods. Int J Food Microbiol 12: 1–8.
  10. 10. Till D, McBride G, Ball A, Taylor K, Pyle E (2008) Large-scale freshwater microbiological study: rationale, results and risks. J Water Health 6: 443–460.
  11. 11. Szymanski CM, King M, Haardt M, Armstrong GD (1995) Campylobacter jejuni motility and invasion of Caco-2 cells. Infect Immun 63: 4295–4300.
  12. 12. Yao R, Burr DH, Doig P, Trust TJ, Niu H, et al. (1994) Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol Microbiol 14: 883–893.
  13. 13. Grant CC, Konkel ME, Cieplak Jr W, Tompkins LS (1993) Role of flagella in adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures. Infect Immun 61: 1764–1771.
  14. 14. Wassenaar TM, Bleumink-Pluym NM, van der Zeijst BA (1991) Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J 10: 2055–2061.
  15. 15. Fernando U, Biswas D, Allan B, Willson P, Potter AA (2007) Influence of Campylobacter jejuni fliA, rpoN and flgK genes on colonization of the chicken gut. Int J Food Microbiol 118: 194–200.
  16. 16. Jin S, Joe A, Lynett J, Hani EK, Sherman P, et al. (2001) JlpA, a novel surface-exposed lipoprotein specific to Campylobacter jejuni, mediates adherence to host epithelial cells. Mol Microbiol 39: 1225–1236.
  17. 17. Monteville MR, Yoon JE, Konkel ME (2003) Maximal adherence and invasion of INT-407 cells by Campylobacter jejuni requires the CadF outer-membrane protein and microfilament reorganization. Microbiology 149: 153–165.
  18. 18. Moser I, Schroeder W, Salnikow J (1997) Campylobacter jejuni major outer membrane protein and a 59-kDa protein are involved in binding to fibronectin and INT-407 cell membranes. FEMS Microbiol Lett 157: 233–238.
  19. 19. Pei Z, Burucoa C, Grignon B, Baqar S, Huang XZ, et al. (1998) Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun 66: 938–943.
  20. 20. Bachtiar BM, Coloe PJ, Fry BN (2007) Knockout mutagenesis of the kpsE gene of Campylobacter jejuni 81116 and its involvement in bacterium-host interactions. FEMS Immunol Med Microbiol 49: 149–154.
  21. 21. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, et al. (2001) A phase-variable capsule is involved in virulence of Campylobacter jejuni 81–176. Mol Microbiol 40: 769–777.
  22. 22. Szymanski CM, Burr DH, Guerry P (2002) Campylobacter protein glycosylation affects host cell interactions. Infect Immun 70: 2242–2244.
  23. 23. Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, et al. (2002) Phase variation of Campylobacter jejuni 81–176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun 70: 787–793.
  24. 24. Louwen R, Heikema A, van Belkum A, Ott A, Gilbert M, et al. (2008) The sialylated lipo-oligosaccharide outer core of Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect Immun 76: 4431–4438.
  25. 25. McSweegan E, Walker RI (1986) Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates. Infect Immun 53: 141–148.
  26. 26. van Putten JP, van Alphen LB, Wösten MM, de Zoete MR (2009) Molecular mechanisms of campylobacter infection. Curr Top Microbiol Immunol 337: 197–229.
  27. 27. Burt S (2004) Essential oils: their antibacterial properties and potential applications in foods-a review. Int J Food Microbiol 94: 223–253.
  28. 28. Di Pasqua R, Betts G, Hoskins N, Edwards M, Ercolini D, et al. (2007) Membrane toxicity of antimicrobial compounds from essential oils. J Agric Food Chem 55: 4863–4870.
  29. 29. Di Pasqua R, Hoskins N, Betts G, Mauriello G (2006) Changes in membrane fatty acids composition of microbial cells induced by addiction of thymol, carvacrol, limonene, cinnamaldehyde, and eugenol in the growing media. J Agric Food Chem 54: 2745–2749.
  30. 30. Helander IM, Alakomi H-L, Latva-Kala K, Mattila-Sandholm T, Pol I, et al. (1998) Characterization of the action of selected essential oil components on Gram-negative bacteria. J Agric Food Chem 46: 3590–3595.
  31. 31. Gill AO, Holley RA (2006) Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics. Int J Food Microbiol 108: 1–9.
  32. 32. Gill AO, Holley RA (2006) Inhibition of membrane bound ATPases of Escherichia coli and Listeria monocytogenes by plant oil aromatics. Int J Food Microbiol 111: 170–174.
  33. 33. Ultee A, Kets EP, Smid EJ (1999) Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 65: 4606–4610.
  34. 34. Ultee A, Smid EJ (2001) Influence of carvacrol on growth and toxin production by Bacillus cereus. Int J Food Microbiol 64: 373–378.
  35. 35. Endtz HP, Giesendorf BA, van Belkum A, Lauwers SJ, Jansen WH, et al. (1993) PCR-mediated DNA typing of Campylobacter jejuni isolated from patients with recurrent infections. Res Microbiol 144: 703–708.
  36. 36. Palmer SR, Gully PR, White JM, Pearson AD, Suckling WG, et al. (1983) Water-borne outbreak of Campylobacter gastroenteritis. Lancet 1: 287–290.
  37. 37. Isberg RR, Voorhis DL, Falkow S (1987) Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 50: 769–778.
  38. 38. Wösten MM, Wagenaar JA, van Putten JPM (2004) The FlgS/FlgR two-component signal transduction system regulates the fla regulon in Campylobacter jejuni. J Biol Chem 279: 16214–16222.
  39. 39. Wösten MM, van Dijk L, Veenendaal AK, de Zoete MR, Bleumink-Pluijm NM, et al. (2010) Temperature-dependent FlgM/FliA complex formation regulates Campylobacter jejuni flagella length. Mol Microbiol 75: 1577–1591.
  40. 40. Gill AO, Holley RA (2006) Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics. Int J Food Microbiol 108: 1–9.
  41. 41. van Alphen LB, Bleumink-Pluym NM, Rochat KD, van Balkom BW, Wösten MM, et al. (2008) Active migration into the subcellular space precedes Campylobacter jejuni invasion of epithelial cells. Cell Microbiol 10: 53–66.
  42. 42. Friedman M, Henika PR, Mandrell RE (2002) Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J Food Prot 65: 1545–1560.
  43. 43. Ravishankar S, Zhu L, Law B, Joens L, Friedman M (2008) Plant-derived compounds inactivate antibiotic-resistant Campylobacter jejuni strains. J Food Prot 71: 1145–1149.
  44. 44. Ultee A, Bennik MH, Moezelaar R (2002) The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 68: 1561–1568.
  45. 45. Isberg RR, Leong JM (1990) Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60: 861–871.
  46. 46. Burt SA, van der Zee R, Koets AP, de Graaff AM, van Knapen F, et al. (2007) Carvacrol induces heat shock protein 60 and inhibits synthesis of flagellin in Escherichia coli O157:H7. Appl Environ Microbiol 73: 4484–4490.
  47. 47. Oussalah M, Callet S, Lacroix M (2006) Mechanism of action of Spanish oregano, Chinese cinnamon, and savory essential oils against cell membranes and walls of Escherichia coli O157:H7 and Listeria monocytogenes. J Food Prot 69: 1046–1055.
  48. 48. Xu H, Delling M, Jun JC, Clapham DE (2006) Oregano, thyme and clone-derived flavors and skin sensitizes activate specific TRP channels. Nat Neuroscience 9: 628–635.
  49. 49. Fabian D, Sabol M, Domaracka K, Bujnakova D (2006) Essential oils- their antimicrobial activity against Escherichia coli and effect on intestinal cell viability. Toxicol In Vitro 20: 1435–1445.
  50. 50. Hagmüller W, Jugl-Chizzola M, Zitterl-Eglseer K, Gabler C, Spergser J (2006) The use of Thymi Herba as feed additive (0.1%, 0.5%, 1.0%) in weanling piglets with assessment of the shedding of haemolysing E. coli and the detection of thymol in the blood plasma. Berl Munch Tierarztl Wochenschr 119: 50–54.
  51. 51. Manzanilla EG, Nofrarías M, Anguita M, Castillo M, Perez JF (2006) Effects of butyrate, avilamycin, and a plant extract combination on the intestinal equilibrium of early-weaned pigs. J Anim Sci 84: 2743–2751.